Podocalyxin expression in malignant astrocytic tumors

被引:35
|
作者
Hayatsu, Norihito [2 ]
Kaneko, Mika Kato [1 ]
Mishima, Kazuhiko [3 ]
Nishikawa, Ryo [3 ]
Matsutani, Masao [3 ]
Price, Janet E. [1 ]
Kato, Yukinari [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Cell Biol, Unit 173, Houston, TX 77030 USA
[2] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan
[3] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama 3501298, Japan
关键词
podocalyxin; keratan sulfate; proteoglycan; astrocytic tumor; glioblastoma;
D O I
10.1016/j.bbrc.2008.07.049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Podocalyxin is an anti-adhesive mucin-like transmembrane sialoglycoprotein that has been implicated in the development of aggressive forms of cancer. Podocalyxin is also known as keratan sulfate (KS) proteoglycan. Recently, we revealed that highly sulfated KS or another mucin-like transmembrane sialoglycoprotein podoplanin/aggrus is upregulated in malignant astrocytic tumors. The aim of this study is to examine the relationship between Podocalyxin expression and malignant progression of astrocytic tumors. in this study, 51 astrocytic tumors were investigated for Podocalyxin expression using immunohistochemistry, Western blot analysis, and quantitative real-time PCR. Immunohistochemistry detected Podocalyxin on the surface Of tumor cells in six of 14 anaplastic astrocytomas (42.9%) and in 17 of 31 glioblastomas (54.8%), especially around proliferating endothelial cells. In diffuse astrocytoma, Podocalyxin expression was observed only in vascular endothelial cells. Podocalyxin might be associated with the malignant progression Of astrocytic tumors, and be a useful prognostic market for astrocytic tumors. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:394 / 398
页数:5
相关论文
共 50 条
  • [1] Expression of cadherin and CSF dissemination in malignant astrocytic tumors
    K. Asano
    O. Kubo
    Y. Tajika
    K. Takakura
    S. Suzuki
    Neurosurgical Review, 2000, 23 : 39 - 44
  • [2] Expression of cadherin and CSF dissemination in malignant astrocytic tumors
    Asano, K
    Kubo, O
    Tajika, Y
    Takakura, K
    Suzuki, S
    NEUROSURGICAL REVIEW, 2000, 23 (01) : 39 - 44
  • [3] Expression of survivin in astrocytic tumors - Correlation with malignant grade and prognosis
    Kajiwara, Y
    Yamasaki, F
    Hama, S
    Yahara, K
    Yoshioka, H
    Sugiyama, K
    Arita, K
    Kurisu, K
    CANCER, 2003, 97 (04) : 1077 - 1083
  • [4] Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
    Kazuhiko Mishima
    Yukinari Kato
    Mika Kato Kaneko
    Ryo Nishikawa
    Takanori Hirose
    Masao Matsutani
    Acta Neuropathologica, 2006, 111 : 483 - 488
  • [5] Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
    Mishima, K
    Kato, Y
    Kaneko, MK
    Nishikawa, R
    Hirose, T
    Matsutani, M
    ACTA NEUROPATHOLOGICA, 2006, 111 (05) : 483 - 488
  • [6] MALIGNANT CEREBELLAR ASTROCYTIC TUMORS IN CHILDREN
    SHINODA, J
    YAMADA, H
    SAKAI, N
    ANDO, T
    HIRATA, T
    HIRAYAMA, H
    ACTA NEUROCHIRURGICA, 1989, 98 (1-2) : 1 - 8
  • [7] Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors
    Kato, Yukinari
    Hayatsu, Norihito
    Kaneko, Mika Kato
    Ogasawara, Satoshi
    Hamano, Tetsutaro
    Takahashi, Satoru
    Nishikawa, Ryo
    Matsutani, Masao
    Mishima, Kazuhiko
    Narimatsu, Hisashi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 369 (04) : 1041 - 1046
  • [8] RAF expression in human astrocytic tumors
    Hagemann, Carsten
    Gloger, Jens
    Anacker, Jelena
    Said, Harun M.
    Gerngras, Stefanie
    Kuehnel, Siglinde
    Meyer, Christoph
    Rapp, Ulf Ruediger
    Kaemmerer, Ulrike
    Vordermark, Dirk
    Flentje, Michael
    Roosen, Klaus
    Vince, Giles Hamilton
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (01) : 17 - 31
  • [9] Pleiotrophin expression in astrocytic and oligodendroglial tumors
    Neder, Luciano
    Peria, Fernanda M.
    Marie, Suely K. N.
    Rosemberg, Sergio
    Oba-Shinjo, Sueli M.
    Colli, Benedicto O.
    Gabbai, Alberto A.
    Malheiros, Suzana M. F.
    Okamoto, Oswaldo K.
    Zago, Marco A.
    Carlotti, Carlos G., Jr.
    MODERN PATHOLOGY, 2006, 19 : 146 - 146
  • [10] Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage
    Hofer, S
    Herrmann, R
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (02) : 91 - 95